WallStreetZenWallStreetZen

NYSE: ECVT
Ecovyst Inc Stock Forecast, Predictions & Price Target

Analyst price target for ECVT

Based on 3 analysts offering 12 month price targets for Ecovyst Inc.
Min Forecast
$10.00+51.29%
Avg Forecast
$11.00+66.41%
Max Forecast
$12.00+81.54%

Should I buy or sell ECVT stock?

Based on 3 analysts offering ratings for Ecovyst Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ECVT stock forecasts and price targets.

ECVT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-05
lockedlocked$00.00+00.00%2024-08-05
lockedlocked$00.00+00.00%2024-07-12

1 of 1

Forecast return on equity

Is ECVT forecast to generate an efficient return?
Company
N/A
Industry
31.78%
Market
54.94%

Forecast return on assets

Is ECVT forecast to generate an efficient return on assets?
Company
N/A
Industry
10.21%

ECVT earnings per share forecast

What is ECVT's earnings per share in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$0.46-2.13%
Avg 2 year Forecast
$0.86+82.98%
ECVT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ECVT revenue forecast

What is ECVT's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$751.5M+8.99%
Avg 2 year Forecast
$813.3M+17.96%
Avg 3 year Forecast
$787.0M+14.14%
ECVT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ECVT earnings growth forecast

How is ECVT forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
35.27%
Industry
20.73%
Market
18.33%
ECVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ECVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ECVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ECVT revenue growth forecast

How is ECVT forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
6.71%
Industry
2.58%
Market
8.17%
ECVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ECVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ECVT vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
ECVT$6.61$11.00+66.41%Strong Buy
KOP$36.62$64.00+74.77%Buy
OEC$16.54$23.00+39.06%Hold
MATV$18.01N/AN/A
ODC$64.52N/AN/A

Ecovyst Stock Forecast FAQ

Is Ecovyst Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: ECVT) stock is to Strong Buy ECVT stock.

Out of 3 analysts, 2 (66.67%) are recommending ECVT as a Strong Buy, 1 (33.33%) are recommending ECVT as a Buy, 0 (0%) are recommending ECVT as a Hold, 0 (0%) are recommending ECVT as a Sell, and 0 (0%) are recommending ECVT as a Strong Sell.

If you're new to stock investing, here's how to buy Ecovyst stock.

What is ECVT's earnings growth forecast for 2024-2025?

(NYSE: ECVT) Ecovyst's forecast annual earnings growth rate of 35.27% is forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 20.73%, and it is also forecast to beat the US market's average forecast earnings growth rate of 18.33%.

Ecovyst's earnings in 2024 is $56,019,000.On average, 3 Wall Street analysts forecast ECVT's earnings for 2024 to be $53,574,467, with the lowest ECVT earnings forecast at $51,245,142, and the highest ECVT earnings forecast at $58,233,116.

In 2025, ECVT is forecast to generate $100,160,960 in earnings, with the lowest earnings forecast at $85,020,349 and the highest earnings forecast at $128,112,855.

What is ECVT's revenue growth forecast for 2024-2026?

(NYSE: ECVT) Ecovyst's forecast annual revenue growth rate of 6.71% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.17%.

Ecovyst's revenue in 2024 is $689,491,000.On average, 4 Wall Street analysts forecast ECVT's revenue for 2024 to be $87,525,305,078, with the lowest ECVT revenue forecast at $83,855,687,040, and the highest ECVT revenue forecast at $98,297,499,808. On average, 3 Wall Street analysts forecast ECVT's revenue for 2025 to be $94,721,870,019, with the lowest ECVT revenue forecast at $87,221,211,746, and the highest ECVT revenue forecast at $108,895,926,920.

In 2026, ECVT is forecast to generate $91,659,972,780 in revenue, with the lowest revenue forecast at $90,845,757,352 and the highest revenue forecast at $92,474,188,208.

What is ECVT's forecast return on assets (ROA) for 2024-2026?

(NYSE: ECVT) forecast ROA is N/A, which is lower than the forecast US Specialty Chemicals industry average of 10.21%.

What is ECVT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ECVT price target, the average ECVT price target is $11.00, with the highest ECVT stock price forecast at $12.00 and the lowest ECVT stock price forecast at $10.00.

On average, Wall Street analysts predict that Ecovyst's share price could reach $11.00 by Aug 5, 2025. The average Ecovyst stock price prediction forecasts a potential upside of 66.41% from the current ECVT share price of $6.61.

What is ECVT's Earnings Per Share (EPS) forecast for 2024-2025?

(NYSE: ECVT) Ecovyst's current Earnings Per Share (EPS) is $0.47. On average, analysts forecast that ECVT's EPS will be $0.46 for 2024, with the lowest EPS forecast at $0.44, and the highest EPS forecast at $0.50. In 2025, ECVT's EPS is forecast to hit $0.86 (min: $0.73, max: $1.10).

What is ECVT's forecast return on equity (ROE) for 2024-2026?

(NYSE: ECVT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.